SOFIA (Bulgaria), May 16 (SeeNews) – Bulgaria's financial regulator said on Tuesday it has permitted the publication of a revised buyout offer by drug maker Sopharma [BUL:3JR] for the 22.12% stake in its local peer Unipharm [BUL:59X] which it does not already own.
Sopharma is offering a price of 4.35 levs ($2.46/2.22 euro) apiece for the 1.3 million Unipharm shares, the Financial Supervision Commission (FSC) said on its website.
You can subscribe to our M&A newsletter here
The price is the same as in the previous buyout bid, launched by Sopharma in March, which was suspended by the FSC in April, the financial regulator added.
In December 2016, Sopharma increased its stake in Unipharm by acquiring a further 8.87%.
Sopharma shares traded 0.76% higher at 3.98 levs as at 15:45 CET on Tuesday, as 61,354 of the company shares had changed hands on the Sofia bourse by that hour.
(1 euro=1.95583 levs)